方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 儿童皮肤生活质量指数 (cDLQI)× | 特应性皮炎评分指数（SCORAD）× | |
|---|---|---|
| 领域 | 皮肤病学 | 皮肤病学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1995 | 1993 |
| 提出者≠ | Lewis-Jones MS, Finlay AY | European Task Force on Atopic Dermatitis (ETFAD) |
| 类型≠ | Self-report (parent or child proxy) | Clinician-rated |
| 开创性文献≠ | Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (cDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942-949. DOI ↗ | Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-19. DOI ↗ |
| 别名≠ | cDLQI, Pediatric DLQI | SCORAD Index |
| 相关 | 3 | 3 |
| 摘要≠ | The Children's Dermatology Life Quality Index (cDLQI) is a pediatric-adapted version of the adult DLQI, measuring the impact of skin disease on quality of life in children and adolescents aged 4–16 years. Developed by Lewis-Jones and Finlay in 1995, it uses child-friendly language and addresses domains relevant to childhood (school, leisure, friendships, clothing) rather than work and adult relationships. cDLQI is the standard quality-of-life measure in pediatric dermatology trials and clinical practice. | The SCORAD is a comprehensive clinician-administered tool for measuring the extent and severity of atopic dermatitis (eczema). Developed by the European Task Force on Atopic Dermatitis in 1993, it combines objective clinical assessment with subjective symptom reporting. It is the gold standard for atopic dermatitis severity in clinical trials and dermatology practice. |
| ScholarGate数据集 ↗ |
|
|